1887

Abstract

The envelope of human cytomegalovirus contains a family of disulphide-linked glycoprotein complexes designated gC-I which contain two glycoproteins of 52000 (gp52) and 93000 to 130000 (gp93-130). Epitopes recognized by several of our gC-I gp52-specific monoclonal antibodies (MAbs) were previously assigned to three domains based on reactivity with gC-I in a competitive binding assay. In this report, we have used additional gC-I MAbs to characterize three distinct discontinuous epitopes in the gC-I complexes. Two of these epitopes were in Domain I and one in Domain III. These epitopes were resistant to proteolysis, heat denaturation and SDS treatment. However, the discontinuous epitopes were lost after reduction of disulphide bonds. After digestion of gC-I complexes with chymotrypsin,: two fragments of 43000 (43Κ) and 34000 (34Κ) were obtained which contained all discontinuous and continuous epitopes recognized by our gp52 MAbs. The of these fragments could not be reduced further by longer digestion or by use of other proteases such as trypsin or pronase. The 43Κ fragment contained -linked oligosaccharides not detected in the 34Κ fragment. These oligosaccharides may have prevented a complete proteolytic digestion so that the 34Κ fragment was not always obtained. It was established that 80 to 90% of the mass of these fragments was contributed by gp52. Thus the discontinuous epitopes were composed primarily of gp52 and not gp93-130.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-72-8-1975
1991-08-01
2024-12-03
Loading full text...

Full text loading...

/deliver/fulltext/jgv/72/8/JV0720081975.html?itemId=/content/journal/jgv/10.1099/0022-1317-72-8-1975&mimeType=html&fmt=ahah

References

  1. Banks T., Huo B., Kousoulas K., Spaete R., Pachl C., Pereira L. 1989; A major neutralizing domain maps with the carboxyl-terminal half of the cleaved cytomegalovirus B glycoprotein. Journal of General Virology 70:979–985
    [Google Scholar]
  2. Britt W. J. 1984; Neutralizing antibodies detect a disulphide-linked glycoprotein complex within the envelope of human cytomegalovirus. Virology 135:369–378
    [Google Scholar]
  3. Britt W. J., Auger D. 1986; Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus. Journal of Virology 58:185–191
    [Google Scholar]
  4. Britt W. J., Vugler L. G. 1989; Processing of gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus. Journal of Virology 63:403–410
    [Google Scholar]
  5. Cranage M. P., Kouzarides T., Bankier A. T., Satchwell S., Weston K., Tomlinson P., Barrell B., Hart H., Bell S. E., Minson A. C., Smith G. L. 1986; Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus. EMBO Journal 5:3057–3063
    [Google Scholar]
  6. Farrar G. H., Greenaway P. J. 1986; Characterization of glycoprotein complexes present in human cytomegalovirus envelopes. Journal of General Virology 67:1469–1473
    [Google Scholar]
  7. Gretch D. R., Suter M., Stinski M. F. 1987; The use of biotinylated monoclonal antibodies and streptavidin affinity chromatography to isolate herpesvirus hydrophobic proteins or glycoproteins. Analytical Biochemistry 163:270–277
    [Google Scholar]
  8. Gretch D. R., Kari B., Rasmussen L., Gehrz R. C., Stinski M. F. 1988a; Identification and characterization of three distinct families of glycoprotein complexes in the evelope of human cytomegalovirus. Journal of Virology 62:875–881
    [Google Scholar]
  9. Gretch D. R., Gehrz R. C., Stinski M. F. 1988b; Characterization of a human cytomegalovirus glycoprotein complex (gcI). Journal of General Virology 69:1205–1215
    [Google Scholar]
  10. Ho M. 1982 Cytomegalovirus Biology and Infection New York: Plenum Press;
    [Google Scholar]
  11. Kari B., Gehrz R. 1990; Analysis of human antibody responses to human cytomegalovirus envelope glycoproteins found in two families of disulfide linked glycoprotein complexes designated gC-I and gC-II. Archives of Virology 114:213–228
    [Google Scholar]
  12. Kari B., Lussenhop N., Goertz R., Wabuke-Bunoti M., Radeke R., Gehrz R. 1986; Characterization of monoclonal antibodies reactive to several biochemically distinct human cytomegalovirus glycoprotein complexes. Journal of Virology 60:345–352
    [Google Scholar]
  13. Kari B., Liu Y.-N. C., Goertz R., Lussenhop N., Stinski M. F., Gehrz R. 1990; Structure and composition of a family of human cytomegalovirus glycoprotein complexes designated gC-I (gB). Journal of General Virology 71:2673–2680
    [Google Scholar]
  14. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, London 227:680–685
    [Google Scholar]
  15. Lussenhop N., Goertz R., Wabuke-Bunoti M., Gehrz R., Kari B. 1988; Epitope analysis of human cytomegalovirus glycoprotein complexes using murine monoclonal antibodies. Virology 164:362–372
    [Google Scholar]
  16. Rasmussen L. E., Nelson R. M., Kelsall D. C., Merigan T. C. 1984; Murine monoclonal antibody to a single protein neutralizes the infectivity of human cytomegalovirus. Proceedings of the National Academy of Sciences, U.S.A 81:876–880
    [Google Scholar]
  17. Savvidou G., Klein M., Horne C., Hofmann T., Dorrington K. J. 1981; A monoclonal immunoglobulin G1 in which some molecules possess glycosylated light chains. I. Site of glycosylation. Molecular Immunology 18:793–805
    [Google Scholar]
  18. Spaete R. R., Thayer R. M., Probert W. S., Masiarz F. R., Chamberlin S. H., Rasmussen L., Merigan T. C., Pachl C. 1988; Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage. Virology 167:207–225
    [Google Scholar]
  19. Utz U., Britt W., Vugler L., Mach M. 1989; Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus. Journal of Virology 63:1995–2001
    [Google Scholar]
/content/journal/jgv/10.1099/0022-1317-72-8-1975
Loading
/content/journal/jgv/10.1099/0022-1317-72-8-1975
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error